Delivery Order SPE2DB22D3004-SPE2DB25FQB91

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 80 MG/0.8 MLS, a pharmaceutical product, with a ceiling value of $2,116.32 and a period of performance through March 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 80 MG/0.8 MLS, a pharmaceutical product, with a firm fixed price ceiling value of $1,510.62 and a period of performance through May 12, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $1,510.60 and a period of performance through January 28, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 80 MG/0.8 MLS, a prescription medication, with a ceiling value of $28,060.30 and a period of performance through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $13,996.56 and a period of performance through April 18, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA PEN 40 MG/0.8 MLS, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $5,443.32 and runs through March 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized medication, with a ceiling value of $2,648.17 and a period of performance through January 31, 2025. The contract is a Firm Fixed Price type with no set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $1,888.25 and a completion date of April 4, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,265.90 and a period of performance through April 17, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication, to support military healthcare programs globally. The delivery order has a ceiling value of $2,993.90 and a period of performance ending on March 12, 2025. The contract is a firm fixed-price type with no...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQB91
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 80 MG/0.8 MLS, a specialty medication. The contract has a ceiling value of $1,666.46 and a period of performance through March 31, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/27/25, 11:55 AM